Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases. | Cells | 2019 | 31835352 | PubTator, text mining | PubMed |
| Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer. | Biomark Res | 2019 | 31832192 | PubTator, text mining | PubMed |
| Reducing effect of insulin resistance on alpha-synuclein gene expression in skeletal muscle. | Diabetol Metab Syndr | 2019 | 31827624 | PubTator, text mining | PubMed |
| Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy. | J Hematol Oncol | 2019 | 31815659 | PubTator, text mining | PubMed |
| Gain-Of-Function E76K-Mutant SHP2 Promotes Cell Proliferation, Metastasis, And Tumor Growth In Glioblastoma Through Activation Of The ERK/CREB Pathway. | Onco Targets Ther | 2019 | 31807022 | PubTator, text mining | PubMed |
| Histological and Gene Expression Analysis of the Effects of Menopause Status and Hormone Therapy on the Vaginal Introitus and Labia Majora. | J Clin Med Res | 2019 | 31803317 | PubTator, text mining | PubMed |
| Loss of p57KIP2 expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells. | Proc Natl Acad Sci U S A | 2019 | 31792181 | PubTator, text mining | PubMed |
| The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma. | Neurooncol Adv | 2019 | 31763623 | PubTator, text mining | PubMed |
| PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer. | Cell Mol Biol Lett | 2019 | 31728150 | PubTator, text mining | PubMed |
| Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia. | Hemasphere | 2019 | 31723823 | PubTator, text mining | PubMed |
| Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. | Front Cell Dev Biol | 2019 | 31681762 | PubTator, text mining | PubMed |
| Structure Based Multitargeted Molecular Docking Analysis of Selected Furanocoumarins against Breast Cancer. | Sci Rep | 2019 | 31673107 | PubTator, text mining | PubMed |
| The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner. | Cell Commun Signal | 2019 | 31651330 | PubTator, text mining | PubMed |
| Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities. | Front Pharmacol | 2019 | 31649529 | PubTator, text mining | PubMed |
| Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF. | Cancer Immunol Res | 2019 | 31615815 | PubTator, text mining | PubMed |
| Tyrosine Kinases in Helicobacter pylori Infections and Gastric Cancer. | Toxins (Basel) | 2019 | 31614680 | PubTator, text mining | PubMed |
| Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites. | Cell | 2019 | 31585087 | PubTator, text mining | PubMed |
| Signal flow control of complex signaling networks. | Sci Rep | 2019 | 31582789 | PubTator, text mining | PubMed |
| Circulating extracellular RNAs, myocardial remodeling, and heart failure in patients with acute coronary syndrome. | J Clin Transl Res | 2019 | 31579840 | PubTator, text mining | PubMed |
| From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers. | Cancer Biol Med | 2019 | 31565476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=47